Insulin secretory responses to paired intravenous and oral glucose loads were determined in 38 nonobese individuals classified as normal (nondiabetic) subjects, "mild" diabetics (fasting blood glucose below 105 mg per 100 ml), or "moderate" diabetics (fasting glucose below 192 mg per 100 ml). Studies were also performed in 29 obese persons who were similarly grouped. The intravenous load was given to assess the alacrity of hormonal release after glycemic stimulus, and the oral glucose to determine how the speed of initial insulinogenesis modifies the disposition of ingested carbohydrate.
In the nonobese group, normal subjects responded to massive hyperglycemia after rapid injection of glucose with immediate and maximal outpouring of insulin, in contrast to a desultory insulinogenic response in patients with mild diabetes, and no initial response at all in moderate diabetics. During oral glucose tolerance tests, the much faster clearance of blood sugar in nondiabetic subjects was actually associated with lower absolute insulin output than was found in mildly diabetic patients, since the latter exhibited delayed hyperinsulinemia in concert with prolonged hyperglycemia. Moderate diabetics never showed excessive insulin release despite even greater hyperglycemia. An empirical "insulinogenic index," the ratio relating enhancement of circulating insulin to magnitude of corresponding glycemic stimulus, was used to compare the secretory capacities of respective groups. Despite the higher absolute hormonal output after oral glucose in […] Summary. Insulin secretory responses to paired intravenous and oral glucose loads were determined in 38 nonobese individuals classified as normal (nondiabetic) subjects, "mild" diabetics (fasting blood glucose below 105 mg per 100 ml), or "moderate" diabetics (fasting glucose below 192 mg per 100 ml). Studies were also performed in 29 obese persons who were similarly grouped. The intravenous load was given to assess the alacrity of hormonal release after glycemic stimulus, and the oral glucose to determine how the speed of initial insulinogenesis modifies the disposition of ingested carbohydrate.
In the nonobese group, normal subjects responded to massive hyperglycemia after rapid injection of glucose with immediate and maximal outpouring of insulin, in contrast to a desultory insulinogenic response in patients with mild diabetes, and no initial response at all in moderate diabetics. During oral glucose tolerance tests, the much faster clearance of blood sugar in nondiabetic subjects was actually associated with lower absolute insulin output than was found in mildly diabetic patients, since the latter exhibited delayed hyperinsulinemia in concert with prolonged hyperglycemia. Moderate diabetics never showed excessive insulin release despite even greater hyperglycemia. An empirical "insulinogenic index," the ratio relating enhancement of circulating insulin to magnitude of corresponding glycemic stimulus, was used to compare the secretory capacities of respective groups. Despite the higher absolute hormonal output after oral glucose in mild diabetics, the index revealed that insulin release in normal subjects was proportionally more than twice as great. This relatively greater normal secretory response declared itself shortly after the administration of glucose by either route, and was maintained throughout both tests.
In the 29 obese individuals, differences among groups were essentially the same as in persons of normal weight. Obese nondiabetics did show much larger absolute insulinogenic responses during both tests than did nonobese controls. Since corresponding glucose tolerance curves were also higher, the mean insulinogenic indexes for obese subjects were not statistically greater. Moreover, when comparable glucose curves of obese and nonobese controls Introduction That the normal beta cell responds promptly and proportionally to a rising blood glucose concentration was shown by Metz (1) and confirmed by Seltzer (2) . Moreover, the interpretation invoked by Seltzer, Fajans, and Conn (3) , that the occurrence of symptomatic postprandial hypoglycemia in patients with mild diabetes mellitus might be due to delayed initial release of insulin followed by subsequent excessive hormonal secretion, was suggestively confirmed when Yalow and Berson (4) found subnormal plasma insulin concentrations at 30 minutes during glucose tolerance testing of mild diabetics but supernormal levels at 2 hours. The present study was designed to determine whether this postulated "biochemical inertia" of beta cell response is in fact demonstrable in the earliest stage of clinical diabetes, and, if so, whether it seems causally related to the delayed clearance of postprandial hyperglycemia. We found that both the speed of insulin release and the quantity of insulin secreted per unit of glycemic stimulus are much greater in normal subjects than in the mildest diabetic patients, in both nonobese and obese individuals.
Methods
Paired intravenous and oral glucose loads were given to 32 subjects with normal glucose tolerance; to 21 patients designated as "mild" diabetics, since fasting blood glucose was below 105 mg per 100 ml; and to 14 "moderate" diabetics whose fasting blood glucose was between 106 and 192 mg per 100 ml. Eleven of the normal subjects were obese (20 to For a given height, the mean of the range for "medium frame" was considered 100%, and the criterion of obesity was an actual weight greater than 115%. 324 room (240 C) was used instead of chromatoelectrophoretic separation in a cold room (40 C). In addition strips were bisected and counted in a well-type gamma scintillation counter instead of with a strip scanner. The dose-response curve, the reproducibility of values when the same plasma samples were repeatedly assayed, and the range of values obtained in normal and diabetic patients all duplicated the performance of the original technic.
The criteria for diagnosis of diabetes mellitus were an abnormal standard oral glucose tolerance test as defined by Fajans and Conn (7), in ambulatory and otherwise healthy individuals in whom nonspecific reasons for abnormal glucose turnover had been eliminated. Normal glucose tolerance meant fasting blood glucose below 100 mg per 100 ml, a 1-hour value less than 160 mg per 100 ml, and a 2-hour level below 110 mg per 100 ml. The glucose tolerance test was diagnostic of diabetes if the 1-hour value was 160 mg per 100 ml or more and the 2-hour glucose level was 120 mg per 100 ml or higher. In the mild diabetics, fasting blood glucose was below 100 mg per 100 ml in 15 patients and less than 105 mg per 100 ml in the other 6; in all individuals blood glucose exceeded 160 mg per 100 ml at 1 hour and was well above 120 mg per 100 ml at 2 hours. In the moderate diabetics, since fasting glucose was always higher than 105 mg per 100 ml, blood levels 1 and 2 hours after the oral glucose load greatly exceeded 160 mg per 100 ml and 120 mg per 100 ml, respectively.
Interpretations derived from our findings (see Discussion) depend upon the validity of the following causal relationships between blood glucose concentration and insulin secretion: 1) An acute rise or fall of blood glucose level directly induces an increase or decrease, respectively, of insulin release (1, 2, 8, 9) . 2) During continuous changes in circulating glucose concentrations after carbohydrate loads, the rate of insulin secretion is directly (but not necessarily linearly) proportional to the simultaneous blood glucose level.2 3) Differences between the insulin secretory responsiveness of normal versus diabetic beta cells can be semiquantitated by expressing the magnitude of insulin output per unit of glycemic stimulus, with the resulting ratio representing an empirical "index of insulinogenic reserve" (see Results and Figure 4 ).
In addition, the experimental design was based upon unprovable but reasonable assumptions, namely, that 1) in the Yalow-Berson radioimmunoassay the capacity of 2 Metz (1) reported a straight-line correlation between the log of blood glucose concentration and the log of insulin secretory rate into the pancreaticoduodenal vein of dogs. Similarly, in our study the regression equation relating corresponding blood glucose and plasma insulin values on the ascending limb of the oral glucose tolerance curve in 21 nonobese normal subjects was log Y = 4.02 + 2.93 log X (r = 0.80). However, Colwell and Lein (10) recently showed strictly linear correlation between plasma glucose and insulin levels during the first 30 minutes after ingestion of 200 g glucose by normal subjects, prediabetics, and mild diabetics. endogenous insulin to react with specific antibody is synonymous with biological activity, such that actual concentrations of immunoinsulin content and biological insulin activity per milliliter of plasma are identical; 2) the concentration of glucose in antecubital venous blood is directly proportional to the concomitant glucose level in pancreatic arterial blood; and 3) the insulin content of antecubital venous plasma directly reflects the simultaneous concentration in pancreatic venous plasma.
Results
Nonobese subjects and patients 1) Insulin secretion during intravenous glucose tolerance test (Figure 1 and Tables I and II) . Normal subjects responded immediately and maximally to the massive glycemic stimulus, in contrast to progressively blunted secretory responses in the diabetic groups. At the end of the 5-minute injection into normal subjects, the rise in blood glucose from 72 + 1 mg per 100 ml (mean ± SEM) to 296 + 7 mg per 100 ml was paralleled by an increase in plasma insulin from 10 ± 1 ,uU per ml to 142 ± 14 puU per ml (p < 0.001). t Significance of the difference between nonobese normal subjects and mild diabetics.
Significance of the difference between obese normal subjects and mild diabetics. Significance of the difference between nonobese mild and moderate diabetics.
Significance of the difference between obese mild and moderate diabetics.
mounting hyperglycemia evoked parallel enhancement of plasma insulin from a fasting value of 9 + 2 /AU per ml to a delayed peak of 233 + 42
,uU per ml at 90 minutes, and a much slower decline than in normal subjects. In the moderate diabetics, as fasting blood glucose of 137 ± 11 mg per 100 ml rose to a peak value of 295 ± 27 mg per 100 ml at 90 minutes and then declined to 211 ± 42 mg per 100 ml at 240 minutes, plasma insulin rose sluggishly from a control value of 19 ± 5 ,uU per ml to 103 + 29 ptU per ml at 120 minutes.
The three patterns of insulin secretory response superimposed in Figure 2 again suggest that alacrity of initial insulin release tended to be inversely related to the severity of carbohydrate intolerance, but they especially emphasize that delayed hyperinsulinemia occurred only in the mildly diabetic group.
3) Relation between simultaneous plasma insulin and blood glucose concentrations. Figure 3 shows the patterns of "insulin: glucose ratios" obtained by dividing plasma insulin enhancement above fasting value by corresponding net increase of blood glucose. After both test loads, normal subjects showed a prompt, sustained rise in the insulin: glucose ratio compared to a much slower 8 Figure 4 illustrates how the index of insulinogenic reserve was used to semiquantitate insulin secretory capacity, both to compare the initial hormonal output with the cumulative and "total" responses in each clinical group and to enable comparison between groups. The index was calculated by dividing the area circumscribed by the insulin curve (i.e., increment above fasting level) by the corresponding area circumscribed by the glucose curve. The findings in Table V indicate that whether blood glucose descended from an acutely imposed hyperglycemic apex, or first rose and then fell postprandially, the insulin secretory response was always much greater in normal subjects than in mild diabetics, and was even lower in moderate diabetics. Moreover, the marked differences in insulin secretory capacity were established within the first 10 minutes on the intravenous test (the index was 0.56 + 0.06 for normal subjects and 0.16 + 0.04 for mild diabetics p < 0.001) and within the first 30 minutes after oral glucose (normal index was 3.07 + 0.34, compared to 1.14 + 0.21 in mild diabetics, p < 0.001). For the intravenous test, the "total" insulinogenic index was 0.66 ± 0.07 (100%) for normal subjects, 0.31 ± 0.06 (47%o) for mild diabetics, and 0.12 + 0.04 (18%o), for moderate diabetics. Corresponding over-all indexes after oral glucose were 4.93 + 0.54 (100o), 2.43 ± 0.39 (49%o), and 0.47 +0.13 (10%o). 3 Respective increments above fasting levels, instead of absolute values, were used for two reasons. First, blood glucose and plasma insulin levels remained constant in fasting subjects or patients lying supine for 4 hours (11). In addition, if the absolute instead of incremental glucose value had been used as divisor in calculating the ratio, diabetics with fasting hyperglycemia would have been specifically penalized without materially affecting results in normoglycemic individuals. Table V ).
5) Effect of age on insulin secretory responsiveness ( Figure 5 ). In none of the three groups did age significantly modify the insulinogenic response to intravenous or oral glucose loads. In nonobese normal subjects, circulating hormonal concentrations were the same for 13 (Tables I and II) . Both mean blood glucose and plasma insulin levels were higher during fasting and at all postinjection intervals in obese normal subjects than in nonobese normal subjects. Despite the substantially higher glucose peak at 5 minutes in obese controls (353 + 10 mg per 100 ml, compared to 296 ± 7 mg per 100 ml in the nonobese), respective k values for the disappearance rate of glucose (12) in nonobese normal sub-/LU per ml in nonobese subjects (p < 0.001).
obese subjects after both WVhen the possible influence of slightly greater greater glycemic stimulus average hyperglycemia in the obese group was responding insulin values eliminated by matching the 7 lowest glucose curves )nly at 120 minutes after in overweight controls with the 7 highest curves in subjects of normal weight (Figure 6 ), the nonobese glucose curve actually became slightly :h the lowest glucose higher. Nevertheless, mean plasma insulin levels ding to those of the 7 remained substantially greater in obese subjects, ith the greatest hyper-although wide individual variations within both l glucose tracings were groups now rendered the differences insignificant gh average plasma in-at all points.
:r in the obese group, Obese mild diabetics also demonstrated the lificant at 120 minutes somewhat slow initial rise in plasma insulin levels that nonobese mild diabetics had shown (Table   ; o had higher fasting IV), and it was accentuated by comparison with els than did mild dia-the rapid and excessive outpouring of hormone in t they still showed the obese normal subjects. For example, although arly insulinogenic re-both normal weight and obese mild diabetics had Plasma insulin was virtually the same plasma insulin levels for 3 minutes (much lower hours after the oral glucose load, from 20 minutes 4 ± 41 1uU per ml in until 45 minutes the discrepancy between obese )5), whereafter it rose mild diabetics and obese normal subjects was + 12 1PU per ml at 45 highly significant (p < 0.005). This latter findnobese mild diabetics, ing contrasted with the small differences between ,an insulin values in normal weight groups during the first hour, as did ot significantly greater also the fact that the prolonged hyperinsulinemic ting glucose adminis-plateau in obese mild diabetics (200 ± 30 ,uU per *ial secretory response ml at 60 minutes, and still 202 ± 27 tLU per ml at aracterized the mildly 120 minutes) never exceeded the highest level in body weight, whereas obese normal subjects (274 + 35 ptU per ml at 60 3) Insulin: glucose ratio and the index of insulinogenic reserve. Figure 3 shows that the differences between normal and diabetic secretory responses to glycemic stimulus were as clearly evident in obese individuals as in those of normal weight. During the first 10 minutes after intravenous glucose, the mean net insulin: glucose ratio for normal obese subjects was 0.72 + 0.11, and the corresponding ratio for obese mild diabetics was 0.22 + 0.03 (p < 0.001). After an oral glucose load, the mean ratio for the initial 30 minutes in obese controls was 3.58 0.31, compared to 1.61 + 0.14 (p < 0.001) in obese mild diabetics. When corresponding secretory responses were matched by calculating the insulinogenic index (Table V) (8, 13) which showed that insulin secretory responsiveness of diabetic patients to both acute and chronic glucose loads is inversely proportional to the clinical severity of carbohydrate intolerance, namely, that in early diabetes the initial blunting of the normal swift reaction to postalimentary rise in blood sugar seems to permit evolution of a worsening cycle of a) first, intermittent postprandial hyperglycemia, which results in b) prolonged, excessive stimulation of beta cells, which c) progressively expends insulin secretory reserve, until finally d) fasting hyperglycemia supervenes, signifying unrelenting, around-the-clock stimulation of an already damaged insulinogenic mechanism. Regarding the latter point, even the modest fasting hyperglycemia defining the present "moderate" diabetics was associated with obliteration of the normally rapid beta cell response to intravenous glucose, and, significantly, with absence of the delayed postprandial hyperinsulinemia seen in the "mild" diabetics, which is often accepted uncritically as a constant finding in all adult-onset diabetics.
The reported observations on insulinogenic responsiveness of intact versus diabetic beta cells held true regardless of body weight. In the 29 persons more than 15%o overweight, differences among the three clinical groups were substantially similar to those in the 38 normal weight individuals. When obese versus nonobese members of the same category were compared, the only striking difference was the faster, greater, and more sustained hormonal release after both glucose loads in obese normal subjects than in control subjects of normal weight. This characteristic hyperresponsiveness of obese subjects, originally discovered by Karam and co-workers (14) in mountainous individuals averaging 95 %o above the norm, was also most floridly seen in our two nondiabetics who exceeded 100%o of desirable weight (data not shown). Even including them, however, when individual secretory response was expressed per unit of glycemic stimulus, the much greater absolute hyperinsulinemia of obesity lost statistical meaning (Table V) because glucose tolerance of overweight subjects, albeit still normal, was sufficiently higher than in nonobese controls. When the latter presumed determinant of insulinogenesis was eliminated by matching the highest glucose curves in normal weight controls with the lowest ones in obese subjects (Figure 6 ), the substantial difference that persisted between mean insulin patterns on both tests was again insignificant. At the same time, the general phenomenon of greater hormonal response to glucose loads in overweight normal subjects did suggest that the obese state somehow engenders peripheral insulin resistance (14, 15) .
When nondiabetic and diabetic groups were compared, the greater disparity between mean insulin values of obese normal subjects and obese mild diabetics during the first 45 minutes of the oral test (Table IV) , relative to their nonobese analogues, was clearly due to the hyperinsulinemia of obesity being wiped out by coexistent diabetes.
Within the two diabetic groups themselves, the only remarkable feature was that plasma insulin did become significantly higher in obese mild diabetics a full 20 minutes after starting the intravenous glucose load, which finding again suggested an anti-insulin effect of obesity. In summation, however, critical scrutiny of apparent discrepancies between hormonal release in obese and nonobese counterparts revealed that the twin defects of insulin secretion in early diabetes were not related to the nutritional state of the patient. In a carefully controlled study of comparably mild diabetics, Perley and Kipnis (16) also concluded that the diabetic state is associated with reduced insulin secretory capacity, regardless of body weight.
It was gratifying that values obtained from antecubital venous blood indicated that at least the early insulinogenic response seemed directly related to glucose concentration, irrespective of pool size and other kinetics of glucose and insulin turnover. Assuming that events in the peripheral circulation of man reflect those occurring in the pancreas, many direct studies confirm the idea that the principal normal secretory stimulus is a rising level of pancreatic arterial blood glucose. Both Grodsky and co-workers (17) and Sussman, Vaughan, and Timmer (18) recently showed immediate hormonal discharge after injecting glucose into the arterial supply of the isolated pancreas. In addition, 5 minutes after starting slow administration of glucose via the femoral vein, Seltzer, Allen, and Brennan (9) found an almost threefold rise in mean pancreatic venous insulin concentration when peripheral arterial blood glucose was only 103 ± 6 mg per 100 ml, previous work (2) (20) , Dupre (21) , and Perley and Kipnis (16) all found higher insulin titers when comparable hyperglycemia was produced in man, or the same amount of glucose was given, by the oral versus intravenous route. Three of these groups suggested that 333 SELTZER, ALLEN, HERRON, AND BRENNAN assimilation of carbohydrate in the upper intestine stimulates release of a humoral agent that enhances the insulin-releasing potency of blood glucose level per se. Current work has narrowed the active substance down to glucagon (22) , secretin (23) (24) (25) , or pancreozymin (26) . Whatever physiological role is ultimately ascribed to one or more gastrointestinal hormones, until someone seriously proposes that their deficiency or absence is etiologically related to diabetes mellitus, they remain irrelevant to the present analysis of the initial insulin secretory response to postprandial hyperglycemia and its consequences.
Nevertheless, the present findings did show much greater insulin release after oral glucose loads in all three clinical groups, and regardless of body weight. Different dosage schedules imposed by the experimental design, however, prevented strict comparison of the two secretory patterns for each person. Since peak blood glucose values on the intravenous test were uniformly much lower in obese subjects if dosage was calculated from desirable body weight (11), the injected amount was empirically calculated from actual body weight. On the other hand, since the oral glucose tolerance test served to separate nondiabetic control subjects from mildly diabetic patients by established testing criteria, and also to evoke a standardized "postprandial" beta cell response, the amount was necessarily based upon desirable body weight according to height. Although quantitative matching of paired'insulin outputs was therefore untenable, the two secretory patterns otherwise showed a striking inferential correlation. Normal immediate hormonal release after sudden intense hyperglycemia suggested that a similarly fast response, but smaller and peripherally undetectable, was also activated by postprandially rising blood sugar, and this brisk insulinogenesis should promote avid hepatic and peripheral glucose uptake (27) , which in turn would clear absorptive hyperglycemia with dispatch. Conversely, the blunted capability of mildly diabetic islets to release insulin after the same intravenous bolus of glucose implied an obtunded islet response to oral glucose as well-which relative lack of early insulin activity on hepatic and posthepatic tissues could reasonably account for the delay in metabolizing ingested glucose.
Finally, the precise nature of the lesion rendering the diabetic islet hyporesponsive to rising blood glucose remains unknown. It may well be that this functional defect is itself not the primary lesion of hereditary diabetes, but rather the sequela of an antecedent one. In contrast to our interpretations of our findings, the majority of current opinion views delayed clearance of postprandial hyperglycemia in mild diabetes as reflecting inhibition of insulin-activated glucose transport into peripheral cells (28, 29) . Recently proposed mechanisms underlying this antagonism include intracellular accumulation of free fatty acids (30) and intracellular deficiency of potassium (31) . Suffice it to say that, if peripheral insulin resistance does contribute to increased hormonal demands in clinical diabetes, its existence need not be invoked to explain the present observations. As a compromise, one might suggest that the fundamental diabetic lesion may ultimately turn out to be generalized blockade of normal glucose transport into cells-into beta cells to catalyze release of insulin, and into peripheral cells to serve as energy substrate.
